<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03187457</url>
  </required_header>
  <id_info>
    <org_study_id>NH-03708</org_study_id>
    <nct_id>NCT03187457</nct_id>
  </id_info>
  <brief_title>PreFem: &quot;What Happens to the Vaginal Microbiota When a BV Infection is Treated With Metronidazole?&quot;</brief_title>
  <acronym>PreFem</acronym>
  <official_title>PreFem: &quot;What Happens to the Vaginal Microbiota When a BV Infection is Treated With Metronidazole?&quot;</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Danisco</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Community Pharmacology Services Ltd</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Danisco</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will assess vaginal microbiota levels before and after antibiotic treatment in
      females infected with Bacterial Vaginosis (BV).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This method validation study will endeavour to obtain evidence for:

        -  Recruitment methodology effectiveness

        -  The usefulness of the &quot;Canestest&quot; test as a screening tool

        -  The time required for the vaginal microbiota (particularly Lactobacillus count) to
           return to normal after treatment of BV infection with metronidazole.

        -  The time required for the Nugent Score to return to normal after treatment of BV
           infection with metronidazole.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 4, 2017</start_date>
  <completion_date type="Actual">November 14, 2017</completion_date>
  <primary_completion_date type="Actual">November 14, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in vaginal microbiota assessed with sequencing</measure>
    <time_frame>Baseline, at day 8, and at day 15</time_frame>
    <description>Change in vaginal microbiota is assessed with sequencing at 3 time points (baseline, at day 8 and at day 15 time points post antibiotic treatment.)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Vaginal microbiota/lactobacilli levels with Nugent scoring</measure>
    <time_frame>Baseline, at day 8, and at day 15</time_frame>
    <description>Nugent scoring is used for the evaluation of the vaginal microbiota at baseline, at 8 and 15 day time points post antibiotic treatment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diagnosis of BV with &quot;Canestest&quot;</measure>
    <time_frame>Baseline</time_frame>
    <description>&quot;Canestest&quot; will be used to diagnose BV infection at baseline.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Bacterial Vaginosis</condition>
  <arm_group>
    <arm_group_label>Treatment group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Metronidazole 400 mg 3 times daily for 5 days for Bacterial Vaginosis (BV) infection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Healthy women without Bacterial Vaginosis and without treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Metronidazole</intervention_name>
    <description>Women with Bacterial Vaginosis treated with Metronidazole for 5 days</description>
    <arm_group_label>Treatment group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control: no treatment</intervention_name>
    <description>Healthy women without Bacterial Vaginosis</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Signed informed consent

          -  Female gender

          -  Over 18 years of age

          -  Have a high probability for compliance with and completion of the study

        Exclusion Criteria:

          -  Hypersensitivity to metronidazole --only applies to Group 2.

          -  Post-menopausal defined as at least 12 consecutive months without menstruation

          -  Treatment of BV in last 4 weeks

          -  Clinically significant menstrual irregularities

          -  Suspected presence of STDs or other vaginal infection

          -  Pregnancy

          -  Breast feeding

          -  Participation in other clinical studies which could influence genitourinary tract
             microbiota

          -  Substance abuse

          -  Investigator believes that the participant may be uncooperative and/or noncompliant
             and should therefore not participate in the study
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gordon Crawford, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CPS Research</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CPS Research</name>
      <address>
        <city>Glasgow</city>
        <zip>G20 0XA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 18, 2017</study_first_submitted>
  <study_first_submitted_qc>June 12, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 15, 2017</study_first_posted>
  <last_update_submitted>December 12, 2017</last_update_submitted>
  <last_update_submitted_qc>December 12, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 13, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vaginosis, Bacterial</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metronidazole</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No plan to share IPD</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

